| Literature DB >> 24315438 |
Tamra Lysaght1, Ian Kerridge, Douglas Sipp, Gerard Porter, Benjamin J Capps.
Abstract
Autologous adult stem cells (ASCs) are being administered by physicians for indications that have not been demonstrated as safe and effective in formal clinical trials. Examination of regulatory frameworks across five countries suggests that balancing the demands of research with clinical freedom has created structural weaknesses that are being exploited.Mesh:
Year: 2013 PMID: 24315438 DOI: 10.1016/j.stem.2013.11.013
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633